At the 2015 USC Stevens Student Innovator Showcase, the Athelas team led by Viterbi student Deepika Bodapati won the USC Stevens Transformational Innovation Award – the de facto “best in show” award. Athelas is a low-cost, portable blood-imaging device that uses microfluidics and microscopy to diagnose medical conditions automatically.
On April 21, 2022, Athelas announced that its flagship device, the Athelas Home, has been cleared by the FDA for home-use indication. From a small volume of blood, the Athelas Home measures white blood cells and neutrophil percentages remotely within a patient’s home or other near-patient setting. The system also has the ability to flag the presence of blast cells, immature cells, and other abnormal cell types often found in liquid tumors.
Athelas currently serves over 40,000 patients across thousands of healthcare providers and is the largest provider of remote patient monitoring services in the country. Earlier this year the company was valued at $1.5 billion.